Myocarditis is not a “rare” side effect. It is a killer

Palace chook goes all out to make it tasty:

“Sorry our models couldn’t predict Covid cases 3 weeks ahead, but trust our models about climate change 3 decades into the future.”

Thousands of Australians and millions worldwide have suffered adverse reactions from COVID-19 vaccines. Those reactions include pain, suffering, disability, major physical and psychological damage, loss of employment, loss of quality of life and even death.

Here’s a Twitter link that lists those who died from the vax:

Myocarditis

1/2 Myocarditis from the COVID vaccine. They say this is a “rare” side effect. Look at these over 4 days. Look at how many young people. This is horrific. The vaccine rollout must be stopped immediately.

1/2 Myocarditis from the COVID vaccine. They say this is a "rare" side effect. Look at these over 4 days. Look at how many young people. This is horrific. The vaccine rollout should be stopped immediately. pic.twitter.com/atJvZzvwpp
— Flame (@iamwhoiam63) November 4, 2021

CDC, FDA helping Pfizer pull a fast one again?

Here’s the real reason Comirnaty is not available

It’s all about liability. It will magically become available when the vaccine for children is fully approved, not before.

The reason Comirnaty isn’t available is because those shots would expose the company to liability since the fully-licensed product doesn’t have the liability waiver of the EUA product.

But once the Pfizer vaccine is fully approved in kids, then Pfizer gets liability waiver on all age groups due to a “feature” in federal law for child vaccines (NCVIA). At that time, they are done.

THE UK HAS FALLEN – 85% of Covid-19 deaths are among the Vaccinated, Child deaths have risen by 83% since they were offered the jab, the Covid-19 Vaccines have negative effectiveness as low as -132%

UK drug regulator authorizes Merck’s coronavirus treatment, the first pill “shown to be effective” at treating COVID-19

(Reuters) -Britain on Thursday became the first country in the world to approve a potentially game-changing COVID-19 antiviral pill jointly developed by Merck and Ridgeback Biotherapeutics, in a boost to the fight against the pandemic.